What's Going On With Sonoma Pharmaceuticals Stock Tuesday? Sonoma stock is trading higher on Tuesday after the company announced that it secured U.K. regulatory clearance for its key wound care and dermatology products.
Stay updated with the stocks that are on the move in today's pre-market session. As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
What's going on in today's after hours session After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025 SNOA stock results show that Sonoma Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday Pre-market stock movers are a hot topic as we dive into all of the biggest news traders need to know about on Monday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning!
SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024 SNOA stock results show that Sonoma Pharmaceuticals missed on revenue for the fourth quarter of 2024.
